Sci Rep:有了这项技术,阿尔兹海默病的进展尽在掌握之中!

2017-11-24 佚名 medicalxpress

特文特大学的科学家利用“拉曼”光学技术,现在可以生成受阿尔茨海默病影响的脑组织图像。图像还包括周边区域,已经显示出变化。

现在特文特大学的科学家利用“Raman”光学技术,可以生成受阿尔茨海默病影响的脑组织图像。图像还包括已经显示出变化的周边区域。

阿尔茨海默病与脑组织中蛋白质浓度高的区域相关:斑块和缠结。拉曼成像现在被用来获得这些受影响地区的清晰图像。这是一个有吸引力的技术,因为它显示的信息比涉及的特定蛋白质更多。受到蛋白质存在影响的水和脂质也可以被检测到。研究人员利用这项技术研究了四个脑供体的脑组织,其中三个与阿尔茨海默病有关。

受影响的区域可以通过这种方式以清晰明了的方式展现出来。在图像处理之后,即使是处在健康组织和受影响组织之间的过渡区域也可以显示,这也可以演示疾病在大脑中是如何传播的。同时即使在健康人的脑组织中,也能检测出具有蛋白质活性的小区域。这可能是神经退行性疾病的一个征兆。

Raman显微镜使用激光束来检测化学物质。反射光和散射光能给出样品中存在的物质的指示。在每一个四个大脑样品中,以这种方式检查了4096个光谱。Raman的主要优点在于化学品不需要预处理,而是“无标签”。在化学分析中,Raman已经被证明是一个强大的技术。

在该实验中,Raman被用来检查身体外的脑组织,但它甚至可以在手术中用于“体内”检测特定区域。与MRI,PET和CT成像相比,Raman能够以非常高的精度检测比细胞更小的区域。所以,它可以是一个非常有价值的先进技术。Raman图像现在用于显示神经细胞水平上的蛋白质活性,但由于其灵敏度足够高,可以检测更小的区域 - 就像健康人的大脑样本一样。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=264475, encodeId=0cc02644e5a9, content=阿尔兹海默病技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Nov 26 10:58:21 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402739, encodeId=0b6f1402e395c, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Sun Nov 26 03:20:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263980, encodeId=6bfd26398099, content=很好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Nov 24 16:06:19 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263975, encodeId=d8182639e523, content=好技术.学习了.必须的., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Nov 24 16:04:45 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263943, encodeId=7f7926394380, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Nov 24 12:47:42 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-26 神功盖世

    阿尔兹海默病技术

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=264475, encodeId=0cc02644e5a9, content=阿尔兹海默病技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Nov 26 10:58:21 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402739, encodeId=0b6f1402e395c, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Sun Nov 26 03:20:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263980, encodeId=6bfd26398099, content=很好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Nov 24 16:06:19 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263975, encodeId=d8182639e523, content=好技术.学习了.必须的., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Nov 24 16:04:45 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263943, encodeId=7f7926394380, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Nov 24 12:47:42 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=264475, encodeId=0cc02644e5a9, content=阿尔兹海默病技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Nov 26 10:58:21 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402739, encodeId=0b6f1402e395c, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Sun Nov 26 03:20:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263980, encodeId=6bfd26398099, content=很好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Nov 24 16:06:19 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263975, encodeId=d8182639e523, content=好技术.学习了.必须的., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Nov 24 16:04:45 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263943, encodeId=7f7926394380, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Nov 24 12:47:42 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-24 清风拂面

    很好.谢谢分享

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=264475, encodeId=0cc02644e5a9, content=阿尔兹海默病技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Nov 26 10:58:21 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402739, encodeId=0b6f1402e395c, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Sun Nov 26 03:20:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263980, encodeId=6bfd26398099, content=很好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Nov 24 16:06:19 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263975, encodeId=d8182639e523, content=好技术.学习了.必须的., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Nov 24 16:04:45 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263943, encodeId=7f7926394380, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Nov 24 12:47:42 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-24 1e0f8808m18(暂无匿称)

    好技术.学习了.必须的.

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=264475, encodeId=0cc02644e5a9, content=阿尔兹海默病技术, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/vi_32/fhZdOu27e88Voqh19n8eF8cLplo8L4nicKtH0WnE3KFELXns5XDu8rsiceK2HHDZc2SEStia5VV3Pia2QLMVqlWbHw/0, createdBy=6e012139475, createdName=神功盖世, createdTime=Sun Nov 26 10:58:21 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1402739, encodeId=0b6f1402e395c, content=<a href='/topic/show?id=60ca9e761ce' target=_blank style='color:#2F92EE;'>#阿尔兹海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97761, encryptionId=60ca9e761ce, topicName=阿尔兹海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=be952422716, createdName=habb, createdTime=Sun Nov 26 03:20:00 CST 2017, time=2017-11-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263980, encodeId=6bfd26398099, content=很好.谢谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=70, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM4o2XVpJ6449yqDsjibydI5HnJ8MibGxNn4HZiaZib0bdfibbwoz3KQrIyN9AGxq36ZlZRNicYlPfOOWMtwgsajY6mGNFiaPclFdowjD0/0, createdBy=97bd1338592, createdName=清风拂面, createdTime=Fri Nov 24 16:06:19 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263975, encodeId=d8182639e523, content=好技术.学习了.必须的., beContent=null, objectType=article, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=60791943465, createdName=1e0f8808m18(暂无匿称), createdTime=Fri Nov 24 16:04:45 CST 2017, time=2017-11-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=263943, encodeId=7f7926394380, content=学习了.谢谢., beContent=null, objectType=article, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Fri Nov 24 12:47:42 CST 2017, time=2017-11-24, status=1, ipAttribution=)]
    2017-11-24 惠映实验室

    学习了.谢谢.

    0

相关资讯

Lancet Neurol:至少提前4年!科学家发现嗅觉障碍比认知和运动障碍能更早预测阿尔兹海默病和帕金森:临床大发现

告诉我,你所认为的阿尔兹海默病和帕金森病最早出现的症状是什么?是记忆退化、行动迟缓,还是目光呆滞、身体颤抖?其实,这些都不会在第一时间出现。最早的症状说出来你可能不信,是嗅觉障碍!震惊吗?

从电视剧《深夜食堂》海清发病看阿尔茨海默症病人,如何早期诊断和护理

讲到阿尔茨海默症可能很多读者还不是太熟悉,但要说到老年痴呆症,大家听说的就比较多了。阿尔茨海默症大多发生在老年期,但是不代表年纪轻轻就不会得,如剧中的海清饰演的年轻妈妈,就称早老性痴呆。这也是为什么现在大多数不用“老年痴呆症”去称呼这个病的原因。

Radiology:阿尔兹海默病患者松果体体积减小:回顾性横断面MRI研究

阿尔茨海默病(Alzheimer disease,AD),又叫老年性痴呆,是一种中枢神经系统变性病,起病隐袭,病程呈慢性进行性,是老年期痴呆最常见的一种类型。主要表现为渐进性记忆障碍、认知功能障碍、人格改变及语言障碍等神经精神症状,严重影响社交、职业与生活功能。AD的病因及发病机制尚未阐明,特征性病理改变为β淀粉样蛋白沉积形成的细胞外老年斑和tau蛋白过度磷酸化形成的神经细胞内神经原纤维缠结,以及

阿尔茨海默病协会在美推生活方式干预试验

阿尔茨海默病协会(Alzheimer's Association)今天宣布推出一项投资达2000万美元的两年期临床试验,检验多维生活方式干预是否能够预防认知衰退和痴呆,试验对象为2500名目前没有认知方面疾病症状但后期认知衰退风险会增加的老年人。这项公告在2017年伦敦阿尔茨海默病协会国际会议(AAIC 2017)上做出。这项通过生活方式干预降低风险从而实现保护的大型美国试验(简称US POI

Cell Reprots:MIT大神科学家蔡理慧在神经修复领域取得新突破,有望找回阿尔兹海默病患者失去的记忆

记忆是人类适应其生存环境所需要的最基本能力,也是人们最宝贵的财富。然而,每年有许许多多的人因为阿尔兹海默病(AD)或者意外事故而丧失记忆,对患者以及家人造成了严重的影响。那么有没有办法帮助这些人恢复丧失的记忆呢?

重 Cell:揭示阿尔兹海默病新机制,大脑“清洁工”能量不足,无法清除蛋白斑

TREM2是小胶质细胞表明的一种受体,与阿茨海默病密切相关。携带TREM2特定突变的人患AD的风险高了五倍。近日,一项发表于Cell上的新研究发现,TREM2的高风险突变会导致小胶质细胞能量赤字。当这些细胞在能量亏空情况下工作时,它们无法保护神经元免受蛋白斑的损伤。